Abstract
Venous port system allows for repeated accesses to the bloodstream over time, if treated with caution, up to 5 years with more than 2000 injections. Venous port is located beneath the skin and consists of a capsule commonly made of titanium with one or two injection chambers covered by a thick silicone rubber membrane which is self-sealing. The injection chamber is connected to a radiopaque catheter and should only be perforated by special venous port needles (“noncoring needles”). Training of personnel and patient/family is essential to keep the venous port over a long time. Only trained personnel should carry out the treatment and the procedure should be written and implemented.
Studies from CDC show that up to 70% of all nosocomial bloodstream infections may be prevented and that includes venous port infections. The following chapter focuses on practical measures to control and prevent bloodstream infections from implanted port for prolonged intravascular access.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beekman SE, Henderson DK. Infections caused by percutaneous intravascular devices. In: Mandell, Douglas, Bennests, editors. Principles and practice of infectious diseases. 7th ed. London: Elsevier Churchill Livingstone; 2010. p. 3697–715. and 2015. p. 3310–24.
O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. CDC. 2011, updated 2017.
Anonymous. Guideline. Totally implantable central venous access ports. Center for Healthcare Related Infection Surveillance and Prevention and Tuberculosis Control. Queensland Healthcare. Mar 2013. p. 1–18.
CDC. Basic infection control and prevention plan for outpatient oncology settings. CDC, 9 Nov 2011.
CDC. Bloodstream infection event (central line-associated blood stream infection and non-central line-associated blood stream infection). CDC, Apr 2015.
Regina Qu’Appelle Health Region. Central venous access lines. Port-A-cath. CEAC 1244, Feb 2014.
American Cancer Society. Central venous catheters. National Cancer Institute. Revised 24 Nov 2014.
Vøllo A, Moe PY. The use of venous port. Tidsskr Nor Legeforen. 1992;112:1727–8.
Franco-Lie I, Ingvaldsen B, Andersen BM. Prevention of intravascular infections. Venous Port (Port-a-cath) system for venous access. In: Handbook of hygiene and infection control in hospitals. Oslo: Ullevaal University Hospital; 2008. p. 37–377.
Weinrach LA. Central venous catheters – port. Medline Plus, updated 20 May 2014.
Møller T, Borregaard N, Tvede M, Adamsen L. Patient education – a strategy for prevention of infection caused by permanent central venous catheters in patients with haematological malignancies: a randomized clinical trial. J Hosp Infect. 2005;61:330–41.
Lai YC, Huang LJ, Chen TL, et al. Impact of port-a-cath device management in cancer patients with bacteraemia. J Hosp Infect. 2012;82:281–5.
Sotir MJ, Lewis C, Bisher EB, Ray SM, Soucie JM, Blumberg HM. Epidemiology of devices-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol. 1999;20:187–91.
Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infections. II. Long-term devices. Clin Infect Dis. 2002;34:1362–8.
Viscoli C, Castagnola E. Prophylaxis and empirical therapy for infection in cancer patients. In: Mandell, Douglas, Bennests, editors. Principles and practice of infectious diseases. London: Elsevier Churchill Livingstone; 2005. p. 3442–62.
Vescia S, Baumgartner AK, Jacobs VR, Kiechle-Bahat M, et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19:9–15.
Freire MP, Pierrotti LC, Zerati AE, et al. Infection related to implantable central venous access devices in cancer patients: epidemiology and risk factors. Infect Control Hosp Epidemiol. 2013;34:671–7.
Tang HJ, Chao CM, Lai CC. Port-related nontyphoid Salmonella bacteraemia. Infect Control Hosp Epidemiol. 2015;36:492–3.
Santos PK, Fernandes AM, Figueiredo V, Haneiro S. Superior vena cava syndrome associated with longstanding implantable central venous port. BMJ Case Rep. 2015; https://doi.org/10.1136/bcr-2014-206643.
Samuel B, Ratnasamy C, Vettukattil JJ. Ventricular tachycardia from embolized central venous port. Adv Pediatr Res. 2015;2:9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Andersen, B.M. (2019). Central Implanted Venous Access Port. In: Prevention and Control of Infections in Hospitals. Springer, Cham. https://doi.org/10.1007/978-3-319-99921-0_42
Download citation
DOI: https://doi.org/10.1007/978-3-319-99921-0_42
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99920-3
Online ISBN: 978-3-319-99921-0
eBook Packages: MedicineMedicine (R0)